Alterity Therapeutics Income Statement (2009-2025) | ATHE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2016	Dec2016	Jun2017	Dec2017	Jun2018	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Revenue & cost
Revenue (Quarter)		0.00B		-0.00B		0.00B		0.00B
Gross Profit (Quarter)
Operating items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)		0.00B		-0.00B		-0.00B		-0.00B				-0.01B		-0.01B		-0.01B		-0.01B		-0.01B
Wages, Salaries and Other (Quarter)		0.00B		0.00B		0.00B		0.00B				0.00B		0.00B		0.00B		0.00B		0.00B
Selling, General & Administrative (Quarter)		0.00B		-0.00B		-0.00B		-0.00B				-0.00B		-0.00B		-0.00B		-0.00B		-0.00B
Rent Expense (Quarter)		0.00B		0.00B		0.00B		0.00B				0.00B		0.00B		-0.00B		0.00B		0.00B
Restructuring Costs (Quarter)		0.00B		0.00B		0.00B		0.00B				0.00B		0.00B		0.00B		0.00B		0.00B
Other Operating Expenses (Quarter)		-0.00B		-0.00B		0.00B		0.00B								-0.00B		-0.00B
Operating Expenses (Quarter)		0.00B		-0.00B		-0.01B		-0.00B				-0.01B		-0.01B		-0.01B		-0.01B		-0.01B
Operating Income (Quarter)
EBIT (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)						0.00B		0.00B
Other Non Operating Income (Quarter)		-0.00B		0.00B		-0.00B		-0.00B				-0.00B		-0.00B		0.00B		-0.00B		0.00B
Net income details
EBT (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Profit After Tax (Quarter)		-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Income from Non-Controlling Interests (Quarter)		-0.00B		-0.00B		-0.00B		-0.00B
Income from Continuing Operations (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Consolidated Net Income (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Income towards Parent Company (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Net Income towards Common Stockholders (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Additional items
EPS (Basic) (Quarter)		0.00	0.00	0.00	0.00	0.00	0.00	0.00					0.00		0.00		0.00
EPS (Diluted) (Quarter)		0.00	0.00	0.00	0.00	0.00	0.00	0.00					0.00		0.00		0.00
Shares Outstanding (Quarter)	5.34B	5.34B	5.34B	5.34B	5.34B	5.34B	6.16B	6.16B	8.95B	9,935,919.46B	16.97B	16.97B	24.06B	24.06B	2.43B	2.43B	3.65B	3.65B	6.40B	6.40B
Shares Outstanding (Diluted) (Quarter)	272,293.95B	272,293.95B	272,293.95B	272,293.95B	272,293.95B	272,293.95B	272,293.95B	8,683,279.81B	8.95B	13,234,323.72B	16.97B	24,051,103.27B	24.06B	24.06B	2.43B	2.43B	3.65B	3.65B	6.40B	6.40B
EBITDA (Quarter)		-0.00B	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B	-0.00B					-0.01B		-0.01B		-0.01B
Interest Expenses (Quarter)								-0.00B

Research Tools

Developers

Alterity Therapeutics Income Statement (2009-2025) | ATHE

Research Tools

Developers

Alterity Therapeutics Income Statement (2009-2025) | ATHE

Create an account

Sign In

Reset Password